Individuals with high cholesterol who stay on their statin medications over a 2-year period are healthier than comparable nonadherent individuals, but the overall cost of their care is slightly higher, according to a new study presented at the Academy of Managed Care Pharmacy 2012 Education Conference, in Cincinnati, Ohio, in October.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

From the Academy of Managed Care Pharmacy 2012 Educational Conference: Patients who adhere to statin regimens are healthier, but higher drug spending makes overall care more costly

Newsletter